BDBM50263186 (1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-tolyl-1H-imidazol-4-yl)(4-(quinolin-3-yl)piperazin-1-yl)methanone::CHEMBL514953

SMILES Cc1ccc(cc1)-c1nc(cn1-c1ccc2OCCOc2c1)C(=O)N1CCN(CC1)c1cnc2ccccc2c1

InChI Key InChIKey=QBDYSDATVFHDRE-UHFFFAOYSA-N

Data  2 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50263186   

TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263186((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-tolyl...)
Affinity DataEC50:  0.120nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263186((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-tolyl...)
Affinity DataIC50:  0.200nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263186((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-tolyl...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human CCK2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed